Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Diabetes targets would cost more but the impact would be worth it: here's how

By Justine Ina Davies, Professor of Global Health, Institute for Applied Research, University of Birmingham
David Flood, Research Fellow, University of Michigan
Jennifer Manne-Goehler, Research Fellow in Medicine, Harvard University
Sanjay Basu, Director of Research, Center for Primary Care, Harvard Medical School
Share this article
Targets for diabetes would improve healthy lives, reduce deaths, and be cost effective. But they should not be for managing diabetes alone; they must include treating hypertension.

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter